622 related articles for article (PubMed ID: 12828078)
1. Hepatectomy with chemoembolization for treatment of hepatocellular carcinoma.
Ochiai T; Sonoyama T; Hironaka T; Yamagishi H
Hepatogastroenterology; 2003; 50(51):750-5. PubMed ID: 12828078
[TBL] [Abstract][Full Text] [Related]
2. Hepatic resection for hepatocellular carcinoma in severely cirrhotic livers.
Kaibori M; Matsui Y; Kitade H; Kwon AH; Kamiyama Y
Hepatogastroenterology; 2003; 50(50):491-6. PubMed ID: 12749254
[TBL] [Abstract][Full Text] [Related]
3. The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma.
Zhang Z; Liu Q; He J; Yang J; Yang G; Wu M
Cancer; 2000 Dec; 89(12):2606-12. PubMed ID: 11135222
[TBL] [Abstract][Full Text] [Related]
4. Preoperative transcatheter arterial chemoembolization reduces long-term survival rate after hepatic resection for resectable hepatocellular carcinoma.
Sasaki A; Iwashita Y; Shibata K; Ohta M; Kitano S; Mori M
Eur J Surg Oncol; 2006 Sep; 32(7):773-9. PubMed ID: 16797156
[TBL] [Abstract][Full Text] [Related]
5. Hepatic resection for hepatocellular carcinoma existing with liver cirrhosis.
Ezaki T; Yamamoto K; Yamaguchi H; Sasaki Y; Ishida T; Mori M; Aimitsu S
Hepatogastroenterology; 2002; 49(47):1363-8. PubMed ID: 12239943
[TBL] [Abstract][Full Text] [Related]
6. Pre-operative transarterial chemoembolization for resectable hepatocellular carcinoma adversely affects post-operative patient outcome.
Kim IS; Lim YS; Lee HC; Suh DJ; Lee YJ; Lee SG
Aliment Pharmacol Ther; 2008 Feb; 27(4):338-45. PubMed ID: 18047564
[TBL] [Abstract][Full Text] [Related]
7. Influence of transcatheter arterial chemoembolization on the prognosis after hepatectomy for hepatocellular carcinoma in patients with severe liver dysfunction.
Kaibori M; Tanigawa N; Matsui Y; Saito T; Uchida Y; Ishizaki M; Tanaka H; Kamiyama Y
Anticancer Res; 2006; 26(5B):3685-92. PubMed ID: 17094386
[TBL] [Abstract][Full Text] [Related]
8. [The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma].
Zhang Z; Wu M; Liu Q
Zhonghua Zhong Liu Za Zhi; 1999 May; 21(3):214-6. PubMed ID: 11776840
[TBL] [Abstract][Full Text] [Related]
9. Transcatheter arterial chemoembolization therapy combined with percutaneous ethanol injection for unresectable large hepatocellular carcinoma: an evaluation of the local therapeutic effect and survival rate.
Dohmen K; Shirahama M; Shigematsu H; Miyamoto Y; Torii Y; Irie K; Ishibashi H
Hepatogastroenterology; 2001; 48(41):1409-15. PubMed ID: 11677976
[TBL] [Abstract][Full Text] [Related]
10. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
[TBL] [Abstract][Full Text] [Related]
11. [Influence of different treatment modalities on survival of patients with two -stage resection of unresectable hepatocellular carcinoma].
Fan J; Wu Z; Tang Z
Zhonghua Wai Ke Za Zhi; 2001 Oct; 39(10):745-8. PubMed ID: 16201184
[TBL] [Abstract][Full Text] [Related]
12. Factors predicting survival in advanced T-staged hepatocellular carcinoma patients treated with reduction hepatectomy followed by transcatheter arterial chemoembolization.
Kobayashi A; Takahashi S; Ishii H; Konishi M; Nakagohri T; Gotohda N; Satake M; Furuse J; Kinoshita T
Eur J Surg Oncol; 2007 Oct; 33(8):1019-24. PubMed ID: 17399939
[TBL] [Abstract][Full Text] [Related]
13. A novel intrahepatic arterial chemotherapy after radical resection for advanced hepatocellular carcinoma.
Tanaka S; Shimada M; Shirabe K; Maehara S; Harimoto N; Tsujita E; Sugimachi K; Maehara Y
Hepatogastroenterology; 2005; 52(63):862-5. PubMed ID: 15966221
[TBL] [Abstract][Full Text] [Related]
14. Postoperative adjuvant hepatic arterial infusion of Lipiodol containing anticancer drugs in patients with hepatocellular carcinoma.
Izumi R; Shimizu K; Iyobe T; Ii T; Yagi M; Matsui O; Nonomura A; Miyazaki I
Hepatology; 1994 Aug; 20(2):295-301. PubMed ID: 8045490
[TBL] [Abstract][Full Text] [Related]
15. Use of transcatheter arterial infusion of anticancer agents with lipiodol to prevent recurrence of hepatocellular carcinoma after hepatic resection.
Tanaka K; Shimada H; Togo S; Takahashi T; Endo I; Sekido H; Yoshida T
Hepatogastroenterology; 1999; 46(26):1083-8. PubMed ID: 10370671
[TBL] [Abstract][Full Text] [Related]
16. Significance of reduction surgery in multidisciplinary treatment of advanced hepatocellular carcinoma with multiple intrahepatic lesions.
Wakabayashi H; Ushiyama T; Ishimura K; Izuishi K; Karasawa Y; Masaki T; Watanabe S; Kuriyama S; Maeta H
J Surg Oncol; 2003 Feb; 82(2):98-103. PubMed ID: 12561065
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma: a multivariate analysis of prognostic features in patients treated with hepatic arterial embolization.
Shijo H; Okazaki M; Higashihara H; Koganemaru F; Okumura M
Am J Gastroenterol; 1992 Sep; 87(9):1154-9. PubMed ID: 1325736
[TBL] [Abstract][Full Text] [Related]
18. [Effects of preoperative transcatheter hepatic arterial chemoembolization (TAE) on the prognosis of patients with hepatic carcinoma undergoing tumor resection].
Lu C; Peng S; Jiang X
Zhonghua Wai Ke Za Zhi; 1996 Jul; 34(7):413-5. PubMed ID: 9590793
[TBL] [Abstract][Full Text] [Related]
19. [Role of post-operative transcatheter arterial chemoembolization in hepatocellular carcinoma with different pathological characteristics].
Xi T; Yan ZL; Wang K; Li J; Xia Y; Shen F; Wu MC
Zhonghua Wai Ke Za Zhi; 2007 May; 45(9):587-90. PubMed ID: 17688789
[TBL] [Abstract][Full Text] [Related]
20. Long term outcome and prognostic factors for large hepatocellular carcinoma (10 cm or more) after surgical resection.
Pandey D; Lee KH; Wai CT; Wagholikar G; Tan KC
Ann Surg Oncol; 2007 Oct; 14(10):2817-23. PubMed ID: 17690940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
